References
- Prayle AP, Hurley MN, Smyth AR. Compliance with mandatory reporting of clinical trial res0075lts on ClinicalTrials.gov: cross sectional study. BMJ 2012;344:d7373
- Giel JL. Comparison of results reporting on ClinicalTrials.gov by funding source. Curr Med Res Opin 2011;27(Suppl 1):S8
- Letter from Congress/House of Representatives to FDA Commisioner. 14 February 2012. Available at: http://democrats.energycommerce.house.gov/sites/default/files/documents/Letter_Hamburg_02.14.12.pdf [Last accessed 11 August 2012]
- Letter from Congress/House of Representatives to NIH Director. 14 February 2012. Available at: http://democrats.energycommerce.house.gov/sites/default/files/documents/Letter_Collins_02.14.12.pdf [Last accessed 11 August 2012]
- TEST Act legislation. 2012. Available at: http://markey.house.gov/sites/markey.house.gov/files/documents/TEST%20Act%20legislation_0.pdf [Last accessed 10 August 2012]
- Drazen JM. Transparency for clinical trials - the TEST Act. N Engl J Med 2012;10.1056/NEJMe1209433
- Ross JS, Tse T, Zarin DA, et al. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 2012;344:d7292
- Bourgeois FT, Murthy S, Mandl KD. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010;153:158-66
- Schott G, Pachl H, Limbach U, et al. The financing of drug trials by pharmaceutical companies and its consequences. Part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication. Dtsch Arztebl Int 2010;107:295-301
- Mansi BA, Clark J, David FS, et al. Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective. Mayo Clin Proc 2012;87:424-9
- World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. Available at: http://www.wma.net/en/30publications/10policies/b3/index.html [Last accessed 20 April 2012]
- A Notice by the National Institutes of Health. 2012. Available at: https://www.federalregister.gov/articles/2012/04/16/2012-9083/submission-for-omb-review-comment-request-information-program-on-clinical-trials-maintaining-a [Last accessed 11 August 2012]
- Lester M, Godlew B. ClinicalTrials.gov registration and results reporting: updates and recent activity. J Clin Res Best Pract 2011;7:1-5
- Wager E. Getting research published: An A to Z of Publication Strategy 2nd edn. Oxon, UK: Radcliffe Publishing Ltd, 2005
- Song F, Hing C, Parekh S, et al. Reasons for not publishing studies: a meta-analysis of data from empirical studies (abstract). Sixth International Congress on Peer Review and Biomedical Publication. Vancouver: JAMA and BMJ Publishing Group, 2009
- Woolley KL. Goodbye Ghostwriters!: How to work ethically and efficiently with professional medical writers. Chest 2006;130:921-3
- International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. 2010. Available at: www.icmje.org [Last accessed 11 August 2012]
- American Medical Writers Association. Code of Ethics. Available at: http://www.amwa.org/default.asp?Mode=DirectoryDisplay&id=114 [Last accessed 11 August 2012]
- Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin 2005;21:317-21
- International Society for Medical Publication Professionals. Code of Ethics. Available at: http://www.ismpp.org/ISMPP%20CODE%20OF%20ETHICS%2011_10.PDF [Last accessed 11 August 2012]
- Chipperfield L, Citrome L, Clark J, et al. Authors’ Submission Toolkit: A practical guide to getting your research published. Curr Med Res Opin 2010;26:1967-82
- Woolley KL, Lew RA, Stretton S, et al. Lack of involvement of medical writers and the pharmaceutical industry in publications retracted for misconduct: a systematic, controlled, retrospective study. Curr Med Res Opin 2011;27:1175-82
- Jacobs A. Adherence to the CONSORT guideline in papers written by professional medical writers. The Write Stuff 2010;19:196-200
- Bailey M. Science editing and its effect on manuscript acceptance time. AMWA Journal 2011;26:147-52
- Doroshow JH. Increasing the Efficiency of Clinical Trials: Decreasing Activation Times by Fifty Percent. NCI Cancer Bulletin 2010;7:4
- Bairnsfather S. Results of the 2011 AMWA Salary Survey. AMWA Journal 2012;27:55-6